The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk

Experimental Gerontology

Volumn 35, Issue 4, 2000, Pages 481-487

  Griffin, W S T ^a,b   Nicoll, J A R ^d   Grimaldi, L M E ^c   Sheng, J G ^a   Mrak, R E ^a,b  

^a Div of Endocrinology and Metabolism   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c Neuroimmunology U S Raffaele S ^*  (Italy)

^d INSTITUTE OF NEUROLOGICAL SCIENCES   (United Kingdom)

Author keywords

Alzheimer's disease; Genetic risk; Immunogenetics; Interleukin 1

Indexed keywords

AMYLOID PRECURSOR PROTEIN; INTERLEUKIN 1; PROTEIN S 100;

ALZHEIMER DISEASE; ASTROCYTE; DNA POLYMORPHISM; DYSTROPHY; GENE OVEREXPRESSION; GENETIC RISK; HOMOZYGOSITY; IMMUNOGENETICS; INHERITANCE; NEURITE; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

ALZHEIMER DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; POLYMORPHISM, GENETIC;

EID: 0034233382     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(00)00110-8     Document Type: Review

References (35)

1. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 28:1997;878-881.
2. Barnum S.R., Jones J.L. Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta. Neurosci. Lett. 197:1995;121-124.
3. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Volk B., Berger M. Interleukin-6 and alpha2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114.
4. Brenneman R.E., Page S.W., Schultzberg M., Thomas F.H., Zelazowski P., Burnet P., Avidor R., Sternberg E.M. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms. J. Pharmacol. Exp. Ther. 266:1992;1029-1035.
5. Brenneman D.R., Schultzberg M., Bartfai T., Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58:1992;454-460.
6. Buxbaum J.D., Oishi M., Chen H.I., et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA. 89:1992;10075-10078.
7. Chan S.L., Griffin W.S.T., Mattson M.P. Evidence for Caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease. J. Neurosci. Res. 57:1999;315-323.
8. Das S., Potter H. Expression of the Alzheimer amyloid-promoting factors α1-antichymotrypsin and apolipoprotein E is induced in astrocytes by IL-1. Neuron. 14:1995;447-456.
9. Dinarello C.A., Wolff S.M. The role of interleukin-1 in disease. N. Engl. J. Med. 328:1993;106-113.
10. Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res. Mol. Brain Res. 16:1992;128-134.
11. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8:1988;2485-2490.
12. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.G., Jacobsen J.S., Vitek M.P., Gajdusek D.C. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA. 86:1989;7606-7610.
13. Griffin W.S.T., Stanley L.C., Ling C., White L., Macleod V., Perrot L.J., White C.L. III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
14. Griffin W.S.T., Sheng J.G., Roberts G.W., Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease. J. Neuropath. Exp. Neurol. 54:1995;276-281.
15. Griffin W.S.T., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'Cytokine Cycle' in disease progression. Brain Pathol. 8:1998;65-72.
16. Grimaldi L.M.E., Casadei V.M., Ferri C., Veglia F., Licastro F., Annoni G., Biunno I., De Bellis G., Sorbi S., Mariani C., Griffin W.S.T., Franceschi M. Association of early onset Alzheimer's disease with an Interleukin-1α gene polymorphism. Ann. Neurol. 47:2000;361-365.
17. Keane R.W., Srinivasan A., Foster L.M., et al. Activation of CPP32 during apoptosis of neurons and astrocytes. Cell. 48:1997;168-180.
18. Kligman D., Marshak D.R. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA. 82:1985;7136-7139.
19. Li Y., Liu L., Kang J., Sheng J.G., Barger S.W., Mrak R.E., Griffin W.S.T. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20:2000;149-155.
20. Marshak D.R., Pesce S.A., Stanley L.C., Griffin W.S.T. Increased S100β neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging. 13:1991;1-7.
21. McDowell T.L., Symons J.A., Ploski R., Forre O., Duff G.W. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 38:1995;221-228.
22. Mrak R.E., Sheng J.G., Griffin W.S.T. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;273-279.
23. Nicoll J.A.R., Mrak R.E., Graham D.I., Stewart J., Wilcock G., MacGowan S., Esiri M.M., Murray L.S., Dewar D., Love S., Moss T., Griffin W.S.T. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 47:2000;365-368.
24. Pociot F., Molvig J., Wogensen L., Worsaae H., Nerup J.A. TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 22:1992;396-402.
25. Rogers J.T., Leiter L.M., McPhee J., Cahill C.M., Zhan S.S., Potter H., Nilsson L.N. Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274:1999;6421-6431.
26. Sheng J.G., Mrak R.E., Griffin W.S.T. S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:1994;398-404.
27. Sheng J.G., Mrak R.E., Griffin W.S.T. Interleukin-1 expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 21:1995;290-301.
28. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., Griffin W.S.T. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
29. + astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56:1997;285-290.
30. Sheng J.G., Mrak R.E., Griffin W.S.T. Progressive neuronal injury associated with amyloid plaque formation in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 57:1998;714-717.
31. Sheng J.G., Mrak R.E., Griffin W.S.T. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 24:1998;278-283.
32. Sheng J.G., Zhou X.Q., Mrak R.E., Griffin W.S.T. Progressive neuronal injury associated with neurofibrillary tangle formation in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 57:1998;323-328.
33. Sheng J.G., Zhu S.G., Griffin W.S.T., Mrak R.E. Interleukin-1 promotes expression and phosphorylation and tau protein in vivo. Exp. Neurol. 2000;. (in press).
34. Wisniewski K.E., Wisniewski H.M., Wen G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:1985;278-282.
35. Zhu S.G., Sheng J.G., Jones R.A., Brewer M.M., Zhou X.Q., Mrak R.E., Griffin W.S.T. Increased interleukin-1β converting enzyme expression and activity in Alzheimer disease. J. Neuropathol. Exp. Neurobiol. 58:1999;582-587.